Arianna Palladini Selected Research

Arianna Palladini Research Topics

Disease

28	Neoplasms (Cancer) 08/2023 - 04/2005
9	Breast Neoplasms (Breast Cancer) 08/2023 - 08/2007
9	Carcinoma (Carcinomatosis) 10/2022 - 04/2005
7	Neoplasm Metastasis (Metastasis) 11/2022 - 08/2007
7	Rhabdomyosarcoma 01/2021 - 03/2006
7	Carcinogenesis 04/2019 - 04/2005
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 10/2020
2	Sarcoma (Soft Tissue Sarcoma) 02/2010 - 03/2006
1	Papillomavirus Infections 08/2023
1	Hypoxia (Hypoxemia) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2019
1	Hepatitis B 01/2018
1	Papilloma (Papillomatosis) 01/2018
1	Noncommunicable Diseases 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018

Drug/Important Bio-Agent (IBA)

15	VaccinesIBA 08/2023 - 04/2005
7	AntibodiesIBA 10/2022 - 04/2005
4	Monoclonal AntibodiesIBA 10/2022 - 11/2007
4	Insulin-Like PeptidesIBA 04/2019 - 02/2010
4	Interleukin-12 (IL 12)IBA 01/2018 - 04/2005
3	Cancer VaccinesIBA 08/2023 - 11/2007
3	Immune Checkpoint InhibitorsIBA 11/2022 - 10/2020
3	Trastuzumab (Herceptin)FDA Link 10/2022 - 11/2014
2	LigandsIBA 10/2020 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 04/2019 - 01/2014
2	Oncogene Proteins (Oncogene Protein)IBA 08/2017 - 01/2013
2	Protein Isoforms (Isoforms)IBA 08/2017 - 11/2014
2	AntigensIBA 06/2011 - 07/2007
2	Interferon-gamma (Interferon, gamma)IBA 03/2009 - 04/2005
1	Drug CombinationsIBA 01/2023
1	Tyrosine Kinase InhibitorsIBA 11/2022
1	CrizotinibIBA 11/2022
1	Virus-Like Particle VaccinesIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2022
1	Sunitinib (Sutent)FDA Link 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	ClaudinsIBA 11/2021
1	EnzymesIBA 01/2021
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	InterferonsIBA 10/2020
1	Sirolimus (Rapamycin)FDA Link 10/2020
1	Mitogen-Activated Protein KinasesIBA 10/2020
1	tyrosine receptor (receptor, tyrosine)IBA 04/2019
1	Phosphotransferases (Kinase)IBA 04/2019
1	human ERBB2 proteinIBA 04/2019
1	Neutralizing AntibodiesIBA 02/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Caveolin 1IBA 01/2019
1	CarcinogensIBA 01/2018
1	Histocompatibility Antigens (Histocompatibility Antigen)IBA 01/2018
1	Epidermal Growth Factor (EGF)IBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2017
1	PerforinIBA 05/2015
1	Interleukin-15 (Interleukin 15)IBA 05/2015
1	DNA VaccinesIBA 01/2014
1	NVP-BKM120IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 11/2010
1	ErbB-2 ReceptorIBA 11/2010
1	ProteomeIBA 11/2010
1	AutoantibodiesIBA 11/2010
1	dactolisibIBA 02/2010
1	Interleukin-4 (Interleukin 4)IBA 04/2009
1	Myosins (Myosin)IBA 04/2009
1	MyogeninIBA 04/2009
1	Tamoxifen FDA LinkGeneric 03/2009
1	Histocompatibility Antigens Class IIBA 11/2007
1	InterleukinsIBA 11/2007
1	Chemokine ReceptorsIBA 08/2007
1	Combined VaccinesIBA 07/2007
1	Tumor Viral Antigens (Large T Antigen)IBA 07/2007
1	Messenger RNA (mRNA)IBA 01/2007
1	Connective Tissue Growth FactorIBA 01/2007
1	Endothelin-3 (Endothelin 3)IBA 03/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2006
1	Peptides (Polypeptides)IBA 03/2006
1	ChemokinesIBA 04/2005

Therapy/Procedure

10	Therapeutics 10/2022 - 11/2007
3	Immunotherapy 08/2023 - 10/2020
1	Aftercare (After-Treatment) 01/2021
1	Intravenous Injections 02/2019